Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOFACITINIB Cause Thrombosis? 1,143 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 1,143 reports of Thrombosis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.7% of all adverse event reports for TOFACITINIB.

1,143
Reports of Thrombosis with TOFACITINIB
0.7%
of all TOFACITINIB reports
86
Deaths
420
Hospitalizations

How Dangerous Is Thrombosis From TOFACITINIB?

Of the 1,143 reports, 86 (7.5%) resulted in death, 420 (36.7%) required hospitalization, and 126 (11.0%) were considered life-threatening.

Is Thrombosis Listed in the Official Label?

Yes, Thrombosis is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.

What Other Side Effects Does TOFACITINIB Cause?

Drug ineffective (30,382) Pain (21,659) Condition aggravated (16,925) Arthralgia (15,640) Fatigue (13,551) Rheumatoid arthritis (12,277) Off label use (11,736) Headache (11,061) Joint swelling (10,686) Malaise (9,040)

What Other Drugs Cause Thrombosis?

LENALIDOMIDE (6,433) APIXABAN (5,298) RIVAROXABAN (3,220) ADALIMUMAB (2,334) POMALIDOMIDE (1,158) RITUXIMAB (1,083) ETANERCEPT (1,051) METHOTREXATE (981) PREDNISONE (963) WARFARIN (925)

Which TOFACITINIB Alternatives Have Lower Thrombosis Risk?

TOFACITINIB vs TOFERSEN TOFACITINIB vs TOLNAFTATE TOFACITINIB vs TOLODODEKIN ALFA TOFACITINIB vs TOLTERODINE TOFACITINIB vs TOLVAPTAN

Related Pages

TOFACITINIB Full Profile All Thrombosis Reports All Drugs Causing Thrombosis TOFACITINIB Demographics